Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. (CELZ) filed this Form 8-K on December 20, 2023, to report the results of its 2023 Annual Meeting of Stockholders held on the same date. The company is incorporated in Nevada and trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
There are no material financial changes reported in this document. The filing details the voting outcomes for three specific proposals at the Annual Meeting:
- Proposal I (Election of Directors): All five nominees were elected to the Board.
- Proposal II (Executive Compensation): The compensation of named executive officers was approved.
- Proposal III (Auditor Ratification): The appointment of Haynie & Company as independent registered public accountants was ratified.
Guidance, Outlook, and Risks
The filing contains no management guidance, future outlook, risk factors, contingencies, or discussion of unusual items. It strictly reports the procedural results of the shareholder vote.
Investor Verification Checklist
- Verify the specific vote counts for the executive compensation proposal (Proposal II), which received 169,498 "For" votes versus 90,645 "Against" votes.
- Confirm the quorum status: 776,982 shares (55.9% of outstanding shares) were present or represented.
- Review the definitive Proxy Statement filed on November 3, 2023, for detailed biographies of the elected directors and specifics on executive compensation.
- Check subsequent filings (10-K or 10-Q) for the company's actual financial performance, as this 8-K contains no financial data.